![]()
|
|
||||||||
J. Biol. Chem., Vol. 275, Issue 51, 40434-40442, December 22, 2000
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
From the Departments of Vascular smooth muscle cells (VSMC) at
capacitance arteries of hypertensive individuals and animals undergo
dramatic polyploidization that contributes toward their hypertrophic
phenotype. We report here the identification of a defective mitotic
spindle cell cycle checkpoint in VSMC isolated from capacitance
arteries of pre-hypertensive rats. These cells demonstrated a high
predisposition to polyploidization in culture and failed to maintain
cyclin B protein levels in response to colcemid, a mitotic inhibitor.
Furthermore, this altered mitotic spindle checkpoint status was
associated with the overexpression of Cks1, a Cdc2 adapter protein that
promotes cyclin B degradation. Cks1 up-regulation, cyclin B
down-regulation, and VSMC polyploidization were evidenced at the smooth
muscle of capacitance arteries of genetically hypertensive and
Goldblatt-operated rats. In addition, angiotensin II infusion
dramatically increased Cks1 protein levels at capacitance arteries of
normotensive rats, and angiotensin II treatment of isolated VSMC
abrogated their ability to down-regulate Cks1 and maintain cyclin B
protein expression in response to colcemid. Finally, transduction of
VSMC from normotensive animals with a retrovirus that drives the
expression of Cks1 was sufficient to alter their mitotic spindle cell
cycle checkpoint status and promote unscheduled cyclin B metabolism,
cell cycle re-entry, and polyploidization. These data demonstrate that
Cks1 regulates cyclin B metabolism and ploidy in VSMC and may
contribute to the understanding of the phenomena of VSMC
polyploidization during hypertension.
Cks1 Mediates Vascular Smooth Muscle Cell Polyploidization*
,
,
, and
**
Genetics and
§ Physiology & Biophysics, Case Western Reserve University
School of Medicine, Cleveland, Ohio 44106, the ¶ Department of
Pathology, H. Lee Moffitt Cancer Center and Research Institute,
University of South Florida, Tampa, Florida 33612, and the
Department of Cardiovascular & Metabolic Diseases, Pfizer Global
Research & Development, Groton Laboratories,
Groton, Connecticut 06340
*
This work was supported in part by American Heart
Association Grant 9750205N, Ohio Cancer Research Associates
(OCRA) Grant 6425276, and National Institutes of Health Grants
HL41618 and HD21341.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
This article has been cited by other articles:
![]() |
Y. Gui, H. Yin, J.-Y. He, S.-H. Yang, M. P. Walsh, and X.-L. Zheng Endoreduplication of human smooth muscle cells induced by 2-methoxyestradiol: a role for cyclin-dependent kinase 2 Am J Physiol Heart Circ Physiol, March 1, 2007; 292(3): H1313 - H1320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. R. Jones and K. Ravid Vascular Smooth Muscle Polyploidization as a Biomarker for Aging and Its Impact on Differential Gene Expression J. Biol. Chem., February 13, 2004; 279(7): 5306 - 5313. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |